If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWindar Photo Regulatory News (WPHO)

  • This share is currently suspended. It was suspended at a price of 27.00

Share Price Information for Windar Photo (WPHO)

Share Price is delayed by 15 minutes
Get Live Data
27.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £26.52m
WPHO Live PriceLast checked at - London Stock Exchange

Intraday Windar Photo Share Chart

Trading Update & £20m Share Subscription Facility

15 Apr 2026 07:00

RNS Number : 4804A
Windar Photonics PLC
15 April 2026
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

15 April 2026

 

("Windar" or the "Company")

 

 

Trading Update, £20 Million Share Subscription Facility, Distribution Agreement

 & CEO Appointment Update

 

 

Windar Photonics plc (AIM: WPHO), the technology group that has developed a LiDAR wind sensor and software suite designed to monitor and optimise wind turbine performance across multiple turbine platforms, today announces:

 

· Record number of new test orders in Q1 2026

· FY 2026 guidance supported by a significant pipeline

· £20 million Share Subscription Facility agreed with GEM Global Yield LLC SCS

· Distribution partnership with Resolux, a leading wind turbine component supplier in Brazil

· Final stages of CEO appointment

 

Q1 2026 Trading

 

The Company has had its strongest ever first quarter in terms of new test order activity. Windar is currently engaged in, or about to commence, ten tests simultaneously across Asia, Europe, Australia and North America. The Independent Power Producers ("IPPs") commissioning these tests together operate more than 10,000 turbines - making this by far the most extensive concurrent testing programme in the Company's history. We are confident this programme establishes a strong foundation for meaningful new sales revenue from the second half of 2026.

 

FY 2026 Outlook

 

The Company expects to deliver revenue of at least €7.8m in FY 2026, representing growth of at least 22% over the prior year, with Adjusted EBITDA of at least €0.5m.

 

This guidance reflects confirmed visibility across our current pipeline and is based on conversion of 50% of our ten active test orders - a threshold we are confident in achieving. It does not include additional revenue opportunities currently being pursued, nor the contribution from the upcoming launch of our Turbine Performance Management software. Both represent meaningful potential upside to the numbers stated here.

 

As we have noted previously, revenue in any given period can be significantly influenced by the timing of large individual orders, a characteristic of the sector rather than the business. Where order timing accelerates, revenue could be substantially higher than the figures stated above.

 

FY 2025 Results

 

For the twelve months to 31 December 2025, the Company expects to report (subject to audit), record revenue of €6.4m representing growth of approximately 39% over 2024. This performance is expected to lead to a 20% reduction in EBITDA loss to €0.4m compared to the prior year whilst also continuing to be backed by a strong balance sheet with net cash of €4.4m as at 31 December 2025. Full year results will be announced in May 2026.

 

£20 Million Share Subscription Facility

 

The Company has signed a binding agreement with GEM Global Yield LLC SCS ("GEM") for the implementation of a Share Subscription Facility ("SSF") with a total commitment from GEM of up to £20 million.

 

GEM is an investment vehicle of Global Emerging Markets, a $3.4 billion alternative investment group with offices in Paris, New York, and Nassau (Bahamas). Global Emerging Markets manages a diverse set of investment vehicles focused on emerging markets and has completed over 570 transactions in 70 countries. Each investment vehicle has a different degree of operational control, risk-adjusted return, and liquidity profile. The investment vehicles provide Global Emerging Markets and its partners with exposure to: Small-Mid Cap Management Buyouts, Private Investments in Public Equities and select venture investments. 

 

For more information: http://www.gemny.com

 

Under the terms of the SSF, Windar has the right, but not the obligation, to draw down capital periodically over a three-year period by issuing new shares to GEM. The Company retains full control over the timing and amount of any drawdown. Future subscription prices will correspond to 90% of the average closing bid prices on the London Stock Exchange during the 15 trading days following each drawdown notice. In connection with the SSF, the Company has issued warrants enabling GEM to purchase up to 5,500,000 ordinary shares at a strike price of £0.75 per share. In addition, Windar has paid a commitment fee of £400,000 to GEM Yield Bahamas Limited, an affiliate of GEM, which it has satisfied by the issue of 1,510,004 ordinary shares in the Company (the "Fee Shares").

 

The SSF has been structured to give Windar the financial flexibility to fulfil large orders and accelerate commercial growth without the delays or dilution risk associated with traditional equity raises. The Company's existing cash position remains strong; the SSF ensures that capital availability will not constrain Windar's ability to convert the current pipeline into revenue.

 

Distribution Agreement - Brazil

 

The Company has entered into a distribution agreement with Resolux, marking its first formal route to market in Brazil. Resolux is a globally recognised supplier of electrical and mechanical components to the wind industry, with an established local presence and long-standing relationships with major wind turbine manufacturers. Brazil's wind sector - currently comprising approximately 9,300 onshore turbines across more than 800 wind farms - represents one of the world's most dynamic growth markets for wind energy, and Windar is well-positioned to capture that opportunity through this partnership.

 

CEO Appointment

 

The Company has made good progress on the appointment of a new CEO and is in the final stages of reaching agreement with its preferred candidate.

 

Admission and Total Voting Rights

  

Application has been made for the Fee Shares to be admitted to trading on AIM ("Admission"). Admission is expected to become effective on 16 April 2026.

 

Upon Admission, the Company's issued ordinary share capital will consist of 98,236,774 ordinary shares, none of which are held in treasury. The above figure of 98,236,774 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

David Lis, Executive Chairman, commented

 

"Our pipeline has never been stronger. Ten simultaneous test orders with IPPs operating more than 10,000 turbines is a clear signal that the market is taking our technology seriously, and our Q1 performance gives us real confidence in the year ahead.

 

The GEM facility is an important step. Our cash position is solid, but access to flexible capital on our terms - deployed when we choose, without the friction of traditional fundraising - gives us the ability to move quickly when large orders come in. GEM's support, backed by a $3.4 billion platform and a 570-transaction track record, is a vote of confidence in both the business and the opportunity in front of us.

 

We look forward to updating shareholders further when we announce our FY 2025 results in May."

 

 

For further information, please contact:

 

Windar Photonics plc

 

David Lis, Interim Executive Chairman

Søren Belmar, CFO / COO

Via Novella

Tel: +45 53527276

Zeus (Nominated Adviser and Broker)

 

David Foreman / James Bavister

Tel: +44 (0) 20 3829 5000

Novella Communications

 

Tim Robertson / Aeliya Bilgrami

Tel: +44 (0) 20 3151 7008

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEANLLFSLKEFA
Date   Source Headline
3rd May 202410:37 amRNSDirectors Dealing / PDMR Shareholding
22nd Apr 20249:38 amRNSDirector Dealing
18th Apr 20245:30 pmRNSDirector dealing / PDMR shareholding
12th Apr 20244:48 pmRNSResult of Oversubscribed Placing and Subscription
12th Apr 20243:44 pmRNSProposed equity fundraising
10th Apr 20247:00 amRNSJohan Blach Petersen
8th Apr 20247:00 amRNSNew Order, Trading Update and Proposed Placing
22nd Feb 20247:00 amRNSLaunch of Windar Nexus software Suite
14th Feb 20247:00 amRNSDirectorate Change
9th Feb 20245:51 pmRNSTR-1
9th Feb 20242:14 pmRNSDirectors Dealing / PDMR Shareholding
6th Feb 20247:13 amRNSNew Order Update and Sales Agency Agreement
3rd Jan 20247:00 amRNSIssue of Equity & Director/PDMR Shareholding
8th Dec 202312:29 pmRNSDirectors Dealing / PDMR Shareholding
8th Dec 20237:00 amRNSNew Order and Trading Update
6th Nov 20231:36 pmRNSDirector/PDMR Shareholding
1st Nov 20238:00 amRNSDirectors Dealing / PDMR Shareholding
9th Oct 20233:28 pmRNSDirectors Dealing / PDMR Shareholding
6th Oct 20237:01 amRNSDirectors Dealing / PDMR Shareholding
6th Oct 20237:00 amRNSDirectorate Changes
2nd Oct 20237:00 amRNSDirector Dealing
28th Sep 20234:28 pmRNSDirector dealing / PDMR shareholding
25th Sep 20237:00 amRNSInterim Results
11th Jul 20234:48 pmRNSResults of AGM
23rd Jun 20239:13 amRNSDirector Dealing
20th Jun 20237:00 amRNSDirector Dealing
13th Jun 20237:00 amRNSFinal Results and Notice of AGM
12th Apr 20237:00 amRNSNew WindVision™ order in China
7th Mar 20234:35 pmRNSPrice Monitoring Extension
12th Jan 20234:40 pmRNSSecond Price Monitoring Extn
12th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Jan 202312:16 pmRNSDirector Dealing
3rd Jan 20239:39 amRNSTR1: Notification of Major Holdings
30th Dec 20227:00 amRNSIssue of Equity
28th Dec 202211:44 amRNSReplacement - Director Dealing
28th Dec 20227:00 amRNSDirector Dealing
21st Dec 20224:34 pmRNSResult of AGM
19th Dec 20227:00 amRNSChange of Nominated Adviser & Director Appointment
5th Dec 20227:00 amRNSDirector Dealing
1st Dec 202210:20 amRNSDirector Dealing
1st Dec 20227:00 amRNSAdditional Test Orders from Vestas
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:36 pmRNSPrice Monitoring Extension
30th Nov 20222:05 pmRNSSecond Price Monitoring Extn
30th Nov 20222:00 pmRNSPrice Monitoring Extension
29th Nov 20224:19 pmRNSDirector Dealing
28th Nov 20229:05 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension
28th Nov 20227:37 amRNSUpdate
28th Nov 20227:30 amRNSRestoration - Windar Photonics plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.